Specific in vitro cleavage of Mason-Pfizer monkey virus capsid protein: Evidence for a potential role of retroviral protease in early stages of infection

Virology

Volumn 310, Issue 2, 2003, Pages 310-318

  Rumlová, Michaela ^a   Ruml, Tomáš ^b   Pohl, Jan ^c   Pichová, Iva ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV 1 capsid protein; HIV I protease; M PMV capsid nucleocapsid fusion protein; M PMV protease; Processing

Indexed keywords

PEPTIDE; PROTEINASE; VIRUS ENZYME; VIRUS PROTEIN; CAPSID PROTEIN; GAG PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; IN VITRO STUDY; MASON PFIZER MONKEY VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RETROVIRUS; SEQUENCE HOMOLOGY; VIRUS CAPSID; VIRUS INFECTION; VIRUS NUCLEOCAPSID; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MASON-PFIZER MONKEY VIRUS; PAPAYA MOSAIC VIRUS; RICE STRIPE VIRUS;

AMINO ACID SEQUENCE; ANIMALS; CAPSID PROTEINS; COS CELLS; ENDOPEPTIDASES; GENE PRODUCTS, GAG; HIV PROTEASE; HIV-1; MASON-PFIZER MONKEY VIRUS; NUCLEOCAPSID; VIRUS REPLICATION;

EID: 0037664350     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00128-4     Document Type: Article

References (49)

1. Accola, M.A., Höglund, S., Göttlinger, H.G., 1998. A putative α-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 gag precursor is crucial for viral particle assembly. J. Virol. 72, 2072-2078.
2. Accola, M.A., Strack, B., Gottlinger, H.G., 2000. Efficient particle production by minimal gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type I capsid-p2 and a late assembly domain. J. Virol. 74, 5395-5402.
3. Alin, K., Goff, S.P., 1996. Amino acid substitution in the CA protein of Moloney murine leukemia virus that block early events in infection. Virology 222, 339-351.
4. Berthet-Colominas, C., Novelli, A., Sibai, G., Mallet, F., Cusack, S., 1999. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of H1V-I capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J. 18, 1124-1136.
5. Bodanszky, M., Bodanszky, A., 1984. The Practice of Peptide Synthesis. Springer-Verlag, Berlin.
6. Bowzard, J.B., Wills, J.W., Craven, R.C., 2001. Second-site suppressors of Rous sarcoma vires CA mutations: evidence for interdomain interactions. J. Virol. 75, 6850-6856.
7. Bradac, J., Hunter, E., 1986a. Polypeptides of Mason-Pfizer monkey virus. Virology 150, 491-502.
8. Bradac, J.A., Hunter, E., 1986b. Short communications. Polypeptides of Mason-Pfizer monkey virus. Ill. Translational order of proteins on the gag and env gene specified precursor polypeptides. Virology 150, 503-508.
9. Cairns, T.M., Craven, R.C., 2001. Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants. J. Virol. 75, 242-250.
10. Campos-Otivas, R., Newman, J.L., Summers, M.F., 2000. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J. Mol. Biol. 296, 633-649.
11. Clish, C.B., Peyton, D.H., Barklis, E., 1998. Solution structures of human immunodeficiency virus type 1 (HIV-1) and Moloney murine leukemia virus (MoMLV) capsid protein major-homology-region peptide analogs by NMR spectroscopy. Eur. J. Biochem. 257, 69-77.
12. Comilescu, C.C., Bouamr, F., Yao, X., Carter, C., Tjandra, N., 2001. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein. J. Mol. Biol. 306, 783-797.
13. Craven, R.C., Leure-duPree, A.E., Erdie, C.R., Wilson, C.B., Wills, J.W., 1993. Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein. J. Virol. 67, 6246-6252.
14. Craven, R.C., Leure-duPree, A.E., Weldon Jr., R.A., Wills, J.W., 1995. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J. Virol. 69, 4213-4227.
15. Dorfman, T., Bukovsky, A., Ohagen, A., Hoglung, S., Gottlinger, H.G., 1994. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68, 8180-8187.
16. Ehrlich, L.S., Krausslich, H.G., Wimmer, E., Carter, C.A., 1990. Expression in Escherichia coli and purification of human immunodeficiency virus type I capsid protein (p24). AIDS Res. Hum. Retroviruses 6, 1169-1175.
17. Forshey, B.M., von Schwedler, U., Sundquist, W.I., Aiken, Ch., 2002. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76, 5667-5677.
18. Gamble, T.R., Yoo, S., Vajdos, F.F., von Schwedler, U.K., Worthylake, D.K., Wang, H., McCutcheon, J.P., Sundquist, W.I., Hill, C.P., 1997. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278, 849-853.
19. Gitti, R.K., Lee, B.M., Walker, J., Summers, M.F., Yoo, S., Sundquist, W.I., 1996. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273, 231-235.
20. Göttlinger, H.G., Sodroski, J.G., Haseltine, W.A., 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86, 5781-578.
21. Gross, I., Hohenberg, H., Wilk, T., Wiegers, K., Grattinger, M., Muller, B., Fuller, S., Krausslich, H.-G., 2000. A conformafional switch controlling HIV-1 morphogenesis. EMBO J. 19, 103-113.
22. Henderson, L.E., Copeland, T.D., Sowder, R.C., Schultz, A.M., Oroszlan, S., 1988. Analysis of proteins and peptides from sucrose banded HTLV-III, in: Bolognesi, D. (Ed.), Human Retroviruses, Cancer, and A1DS: Approaches to Prevention and Therapy. A.R. Liss, New York, pp. 135-147.
23. Henderson, L.E., Sowder, R., Smythers, G., Benveniste, R.E., Oroszlan, S., 1985. Purification and N-terminal amino acid sequence comparisons of structural proteins from retrovirus-D/Washington and Mason-Pfizer monkey virus. J. Virol. 55, 778-787.
24. Henderson, L.E., Sowder, R.C., Smythers, G.W., Oroszlan, S., 1987. Chemical and immunological characterization of equine infectious anemia virus gag-encoded proteins. J. Virol. 61, 1116-1124.
25. Hruskova-Heidingsfeldova, O., Andreansky, M., Fábry, M., Bláha, I., Strop, P., Hunter, E., 1995. Cloning, bacterial expression, and characterization of the Mason-Pfizer monkey virus proteinase. J. Biol. Chem. 25, 15053-15058.
26. Jin, Z., Jin, L., Peterson, D.L, Lawson, C.L., 1999. Model for lentivirus capsid core assembly based on crystal dimers of E1AV p26. J. Mol. Biol. 286, 83-93.
27. Khorasanizadeh, S., Campos-Olivas, R., Summers, MF., 1999. Solution structure of the capsid protein from the human T-cell leukemia virus type-I. J. Mol. Biol. 291, 491-505.
28. Kingston, R.L., Fitzon-Ostendorp, T., Eisenmesser, E.Z., Schatz, G.W., Vogt, VM., Post, C.B., Rossmann, M.G., 2000. Structure and self-association of the Rous sarcoma virus capsid protein. Structure 8, 617-628.
29. Kraft, J.R., Vance, R.E., Pohl, J., Martin, A.M., Raulet, D.H., Jensen, P.E., 2000. Analysis of Qa1b peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J. Exp. Med. 192, 613-624.
30. Krausslich, H.-G., Facke, M., Heuser, A.M., Konvalinka, J., Zentgraf., H., 1995. The spacer peptide between human immunodeficiency vires capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69, 3407-3419.
31. Parker, S.D., Hunter, E., 2001. Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro. Microbiology 98, 14631-14636.
32. Pepinsky, R.B., Papayannopoulos, I.A., Chow, E.P., Krishna, N.K., Craven, R.C., Vogt, V.M., 1995. Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses. J. Virol. 69, 6430-6438.
33. Pettit, S.C., Moody, M.D., Wehbie, R.S., Kaplan, A.H., Nantermet, P.V., Klein, C.A., Swanstrom, R., 1994. The p2 domain of human immunodeficiency virus type I Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68, 8017-8027.
34. Ratner, L., Fisher, A., Jagodzinski, L.L., Mitsuya, H., Liou, R.-S., Gallo, R.C., Wong-Staal, F., 1987. Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retrovirus 3, 57-69.
35. Reicin, A.S., Paik, S., Berkowitz, R.D., Luban, J., Lowy, I., Goff, S., 1995. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on viral particle assembly, release, and infectivity. J. Virol. 69, 642-650.
36. Rumlová, M., Benediková, J., Cubinková, R., Pichová, I., Ruml, T., 2001. Comparison of classical and affinity purification techniques of Mason-Pfizer monkey virus capsid protein: the alteration of the product by an affinity tag. Prot. Expr. Purif. 23, 75-83.
37. Sambrook, J., Russel, D.W., 2001. Molecular Cloning: A laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
38. Schechter, 1., Berger, A., 1967. On the size of the active site in proteases. 1. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
39. Shehu-Xhilaga, M., Kraeusslich, H.-G., Pettit, S., Swanstrom, R., Lee, J.Y., Marshall, J.A., Crowe, S.M., Mak, J., 2001. Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type I RNA dimer maturation. J. Virol. 75, 9156-9164.
40. Sonigo, P., Barker, C., Hunter, E., Wainhobson, S., 1986. Nucleotide-sequence of Mason-Pfizer monkey virus - an immunosuppressive D-type retrovirus. Cell 45, 375-385.
41. Strambio-de-Castillia, C., Hunter, E., 1992. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 66, 7021-7032.
42. Tobin, G.J., Sowder, R.C., Fabris, D., Hu, M.Y., Battles, J.K., Fenselau, C., Henderson, L.E., Gonda, M.A., 1994. Amino acid sequence analysis of the proteolytic cleavage products of the bovine immunodeficiency virus Gag precursor polypeptide. J. Virol. 68, 7620-7627.
43. Uchida, H., Maeda, Y., Mitsuya, H., 1997. HIV-1 protease does not play a critical role in the early stages of HIV-1 infection. Antiviral Res. 36, 107-113.
44. Weber, J., M.P., Litera, J., Urban, J., Souc̀ek, M., Vondrášek, J., Konvalinka, J., Novek, P., Sedláček, J., Štrop, P., Krausslich, H.G., Pichová, I., 1997. Potency comparison of peptidomimetic inhibitors against HIV-1 and HIV-2 proteinases: design of equipotent lead compounds. Arch. Biochem. Biophys. 341, 62-69.
45. Wiegers, K., Rutter, G., Kottler, H., Tessmer, U., Hohenberg, H., Krausslich, H-G., 1998. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72, 2846-2854.
46. Wills, J.W., Craven, R.C., 1991. Form, function and use of retroviral gag proteins. AIDS 5, 639-65.
47. Worthylake, D.K., Wang, H., Yoo, S., Sundquist, W.I., Hill, C.P., 1999. Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution. Acta Crystallogr. D Biol. Crystallogr. 55, 85-92.
48. Xiang, Y, Thorick, R, Vana, ML, Craven, R, Leis, J., 2001. Proper processing of avian sarcoma/leukosis virus capsid proteins is required for infectivity. J. Virol. 75, 6016-21.
49. Zábranský, A., Andreánsky, M., Hruskova-Heidingsfeldova, O., Havliček V., V., Hunter, E., Ruml, T., Pichovǎ, I., 1998. Three active forms of aspartic proteinase from Mason-Pfizer monkey vires. Virology 245, 250-256.